CO2 Treatment for Obesity

Recruiting in Palo Alto (17 mi)

Overseen byMurad Alam, MD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Northwestern University

No Placebo Group

Trial Summary

What is the purpose of this trial?The primary objective of this study is to demonstrate the efficacy and safety of the carbon dioxide for subcutaneous fat reduction.

Eligibility Criteria

This trial is for men and women aged 18 or older with a BMI between 18.5-24.99, who are in good health and willing to avoid other body contouring treatments or significant lifestyle changes during the study. It's not for pregnant individuals, those unable to consent, people with certain diseases like asthma or skin infections near the treatment area, bleeding disorders, lidocaine allergies, or any condition that could affect their participation.

Inclusion Criteria

Your body mass index, which is a measure of your weight in relation to your height, falls within the range of 18.5 to 24.99.

Subject agrees to maintain their weight (i.e. within 5 pounds) by not making any changes to diet or lifestyle during the study

I agree not to pursue any other body contouring or weight loss treatments during the study.

+7 more

Exclusion Criteria

I have had or will have procedures that might affect my treatment area.

I have a history of asthma or COPD.

I have a bleeding disorder or a condition affecting blood clotting.

+6 more

Participant Groups

The study is testing the effectiveness and safety of carbon dioxide (CO2) treatments for reducing subcutaneous fat compared to a sham procedure (a fake treatment used as a control). Participants will be randomly assigned to receive either CO2 treatments or sham procedures.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: treatmentExperimental Treatment1 Intervention

CO2 treatment

Group II: shamPlacebo Group1 Intervention

sham treatment